TerminatedEUCTR 2013-000240-26

Cannabidiol as an add-on therapy in treatment-refractory psychotic disorders

This historical record does not confirm current site availability.

Historical research recordUnited KingdomSchizophrenia

The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: United Kingdom
Study phase: Phase 2

Get this study by email

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed

Recruitment status: Terminated
Enrollment listed in the registry: Not clearly listed
Sponsor: King's College London [...] 1. King's College London 2. South London and Maudsley NHS Foundation Trust
Sponsor type: University
Study type: Biological
Intervention type: Biological
Study phase: Phase 2
Locations: United Kingdom
Age range: Not clearly listed
Official registry ID: EUCTR 2013-000240-26
Official title: Show the full official title
Cannabidiol as an add-on therapy in treatment-refractory psychotic disorders

Recruitment & locations

Terminated

United Kingdom

Registry details

Historical country statuses

United Kingdom — Prematurely Ended

Interested in joining this study?

FAQ

Questions about this study

Who is behind this study?

The study sponsor is King's College London [...] 1. King's College London 2. South London and Maudsley NHS Foundation Trust, a university.

Is this study still recruiting?

The historical registry lists this study as terminated.

Want to explore more studies?

Explore studies